Lv6
2070 积分 2023-03-06 加入
EASIX score predicts non‐relapse mortality and severe infection in elderly patients undergoing allo‐HSCT
9小时前
待确认
Impact of fludarabine‐based induction therapy on outcome of FLT3−/NPM1+ cytogenetically normal acute myeloid leukemia
21天前
已完结
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation
29天前
已完结
Development of an Endothelial Activation and Stress Index (EASIX)-based predictive model for cytokine release syndrome and neurotoxicity after B-cell maturation antigen directed chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
29天前
已完结
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis
29天前
已完结
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation
1个月前
已完结
How I Treat patients with AML using azacitidine and venetoclax
1个月前
已完结
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
1个月前
已完结
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax
1个月前
已完结
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
2个月前
已完结
皖公网安备34019202002308
